Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Gail_McIntyre
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
oncology
cancer therapeutics |
| gptkbp:founded |
2008
|
| gptkbp:headquartersLocation |
gptkb:Houston,_Texas,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:product |
gptkb:batiraxcept
|
| gptkbp:researchArea |
immuno-oncology
targeted therapies |
| gptkbp:status |
gptkb:public_company
|
| gptkbp:tradedOn |
gptkb:NASDAQ:_ARAV
|
| gptkbp:website |
https://www.aravive.com/
|
| gptkbp:bfsParent |
gptkb:Aravive
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aravive Biologics, Inc.
|